Polycystic ovary syndrome (PCOS)
Conditions
Interventions
Patients with the high LH subtype of PCOS:N/A
Patients with the obese subtype of PCOS:N/A
Patients with the hyperandrogenic subtype of PCOS:N/A
Patients with the high SHBG subtype of PCOS:N/A
control group:N/A
Sponsors
Obstetris & Gynecology Hospital of Fudan University
Eligibility
Sex/Gender
Female
Age
20 Years to 35 Years
Inclusion criteria
Inclusion criteria: 1. Women of reproductive age aged 20–35 years; 2. The PCOS group was diagnosed according to the Rotterdam criteria; 3. Written informed consent was obtained from all participants.
Exclusion criteria
Exclusion criteria: 1. Patients with significant reproductive, endocrine, metabolic or immune disorders; 2. Patients with severe underlying diseases including cardiovascular, cerebrovascular, hepatic, renal insufficiency, as well as hematologic and coagulation disorders; 3. Have used other medications recently; 4. Participants deemed ineligible by the investigators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum sex hormones;Fasting insulin;Anti Mullerian hormone, AMH;Sex Hormone-Binding Globulin, SHBG; | — |
Countries
China
Contacts
Public ContactGao Ling
Obstetris & Gynecology Hospital of Fudan University
Outcome results
None listed